Nosocomial influenza: New concepts and practice

Current Opinion in Infectious Diseases

Volumn 21, Issue 4, 2008, Pages 337-343

  Maltezou, Helen C ^a  

^a Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

Antivirals; Health care workers; Nosocomial influenza; Outbreak; Vaccination

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR; ANTIVIRUS AGENT;

AGING; ANTIGEN DETECTION; CHRONIC DISEASE; DIAGNOSTIC ACCURACY; EUROPE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; NONHUMAN; RESPIRATORY VIRUS; REVIEW; RISK ASSESSMENT; ANTIVIRAL RESISTANCE; CROSS INFECTION; DIAGNOSTIC PROCEDURE; DISEASE TRANSMISSION; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANTIVIRAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MOLECULAR DIAGNOSTIC TECHNIQUES; OSELTAMIVIR;

EID: 49049108554     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283013945     Document Type: Review

References (81)

1. World Health Organization. Influenza fact sheet (Fact Sheet No. 211). http://www.who.int/mediacentre/factsheets/fs211/en/index.html [Accessed 28 January 2008].
2. Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-5096.
3. Ryan J, Zoellner Y, Gradl B, et al. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24:6812-6822.
4. Treanor JD. The goal of control. N Engl J Med 2007; 357:1439-1441.
5. Cruz Rojo J, Ruiz-Contreras J, Baro Fernandez M, et al. Influenza-related hospitalizations in children younger than three years of age. Pediatr Infect Dis J 2006; 25:596-601.
6. Hansen S, Stamm-Balderjahn S, Zuschneid I, et al. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 2007; 65:348-353. A comprehensive review of 1561 nosocomial outbreaks published in the last 40 years with analysis by a etiologic agent, type of infection, mode of transmission, source, and department.
7. Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003; 55:83-91.
8. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002; 2:145-155.
9. Bull AL, Bennett N, Pitcher HC, et al. Influenza vaccine coverage among healthcare workers in Victorian public hospitals. Med J Aust 2007; 186:185-186.
10. Van der Wouden JC, Bueving HJ, Poole P. Preventing influenza: an overview of systematic reviews. Respir Med 2005; 99:1341-1349.
11. Walker FJ, Singleton JA, Lu P, et al. Influenza vaccination of healthcare workers in the United States, 1989-2002. Infect Control Hosp Epidemiol 2006; 27:257-265.
12. Bautista D, Vila B, Uso R, et al. Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers. Infect Control Hosp Epidemiol 2006; 27:73-77.
13. Chan SSW. Does vaccinating ED healthcare workers against influenza reduce sickness absenteeism? Am J Emerg Med 2007; 25:808-811.
14. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomized controlled trial. Br Med J 2006; 333:1241.
15. Borlaug G, Newman A, Pfister J, Davis JP. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005-2006 influenza season. Infect Control Hosp Epidemiol 2007; 28:1398-1400. This study showed for the first time that the use of signed declination forms for HCWs that refuse influenza vaccination was associated with increased vaccine coverage.
16. Bertin M, Scarpelli M, Proctor AW, et al. Novel use of the intranet to document healthcare personnel participation in a mandatory influenza vaccination reporting program. Am J Infect Control 2007; 35:33-37.
17. Dunais B, Saccomano C, Mousnier A, et al. Influenza vaccination: impact of an intervention campaign targeting hospital staff. Infect Control Hosp Epidemiol 2006; 27:529-531.
18. The macroepidemiology of influenza vaccination (MIV) Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 2005; 23:5133-5143.
19. De Juanes JR, Garsia de Codes A, Arrazola MP, et al. Influenza vaccination coverage among hospital personnel over three consecutive vaccination campaigns (2001-2002 to 2003-2004). Vaccine 2007; 25:201-204.
20. Poland GA, Tosh P, Jacobson RM. Requiring influenza vaccination for healthcare workers: seven truths we must accept. Vaccine 2005; 23: 2251-2255.
21. Song JY, Park CW, Jeong HW, et al. Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol 2006; 27:612-617.
22. Nichol KL. First do not harm: ensuring that healthcare workers vaccinate and are vaccinated. Infect Control Hosp Epidemiol 2003; 24:799-800.
23. Trivalle C, Okenge E, Hamon B, et al. Factors that influence influenza vaccination among healthcare workers in a French geriatric hospital. Infect Control Hosp Epidemiol 2006; 27:1278-1280.
24. Piccirillo B, Gaeta T. Survey on use of and attitudes toward influenza vaccination among emergency department staff in a New York metropolitan hospital. Infect Control Hosp Epidemiol 2006; 27:618-622.
25. Ito Y, Sumi H, Kato T. Evaluation of influenza vaccination in health-care workers, using rapid antigen detection test. J Infect Chemother 2006; 12:70-72.
26. Saluja I, Theakston KD, Kaczorowski J. Influenza vaccination rate among emergency department personnel: a survey of four teaching hospitals. Can J Emerg Med 2005; 7:17-21.
27. Maltezou HC, Maragos A, Halharapi T, et al. Factors influencing influenza vaccination rates among healthcare workers in Greek hospitals. J Hosp Infect 2007; 66:156-159. This nationwide study showed for the first time that hospital-related factors may influence vaccine uptake among HCWs.
28. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel. Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:1-16.
29. Fiore AE, Shay DK, Haber P, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2007; 56:1-54.
30. Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007; 196:249-257. This study presents in detail the current status and trends of resistance to admantanes among influenza A viruses collected worldwide.
31. Lackenby A, Hungnes O, Dudman SG, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro Surveill 2008; 13:pii = 8026. This is the first report on the recent emergence of oseltamivir resistance among influenza A/H1N1 strains circulating in Europe.
32. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? BMC Infect Dis 2006; 6:130.
33. Tang JW, Li Y, Eames I, et al. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006; 64:100-114.
34. Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007; 28:1071-1076.
35. Lee I, Barton TD. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007; 67:1411-1427.
36. Kawana A, Teruya K, Kirikae T, et al. 'Syndromic surveillance within a hospital' for the early detection of a nosocomial outbreak of acute respiratory infection. Jpn J Infect Dis 2006; 59:377-379.
37. Outbreak Database. www.outbreak-database.com [Accessed 29 February 2008].
38. Weingarten S, Riedinger M, Bolton LB, et al. Barriers to influenza vaccine acceptance. A survey of physicians and nurses. Am J Infect Control 1989; 17:202-207.
39. Sartor C, Zandotti C, Romain F, et al. Disruption of services in an internal medicine unit due to a nosocomial influenza outbreak. Infect Control Hosp Epidemiol 2002; 23:615-619.
40. Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007; 45:1362-1368. This is an excellent review of the use of antivirals for the control of influenza outbreaks in closed facilities. Several epidemiological aspects of outbreaks are discussed in detail.
41. Badcock HM, Mertz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006; 27:266-270.
42. Meara MO, Brien AO, Feely E, Conlon M. Influenza A outbreak in a community hospital. Ir Med J 2006; 99:175-177.
43. Lopez-Medrano F, Aguado JM, Lizasoain M, et al. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study. Transplantation 2007; 84:851-856.
44. Serwint JR, Miller RM. Why diagnose influenza infections in hospitalized pediatric patients? Pediatr Infect Dis J 1993; 12:200-204.
45. Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 2006; 160:713-718.
46. Hurt AC, Alexander R, Hibbert J, et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007; 39:132-135. In this study the authors compare the performance of six influenza rapid antigen detection tests in real practice.
47. Abanses JC, Dowd MD, Simon SD, Sharma V. Impact of rapid influenza testing at triage on management of febrile infarcts and young children. Pediatr Emerg Care 2006; 22:145-149.
48. Bonner AB, Monroe KW, Talley LI, et al. Impact of the rapid diagnosis of influenza on physician-decision making and patient management in the Pediatric Emergency Department: results of a randomized, prospective, controlled trial. Pediatr 2003; 112:363-367.
49. Slinger R, Dennis P. Nosocomial influenza at a Canadian pediatric hospital from 1995 to 1999: opportunities for prevention. Infect Control Hosp Epidemiol 2002; 23:627-629.
50. Letant SE, Ortiz JI, Bentley Tammero LF, et al. Multiplexed reverse transcriptase PCR assay for identification of viral respiratory pathogens at the point of care. J Clin Microbiol 2007; 45:3498-3505.
51. Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 2006; 78:1498-1504.
52. Mahony J, Chong S, Merante F, et al. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol 2007; 45:2965-2970. A multiplex PCR was developed for the detection of 20 respiratory viruses and might prove cost effective for the investigation of nosocomial outbreaks when large number of specimens should be tested.
53. Mehlmann M, Bonner AB, Williams JV, et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuikVue Influenza A + B test for rapid diagnosis of influenza. J Clin Microbiol 2007; 45:1234-1237.
54. Russell ML, Henderson EA. The measurement of influenza vaccine coverage among health-care workers. Am J Infect Control 2003; 31:457-461.
55. Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in healthcare professionals. JAMA 1999; 281:908-913.
56. Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003; 21: 2207-2217.
57. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006; 194 (Suppl 2):S111-S118.
58. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol 2004; 25:923-928.
59. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:1-6.
60. Cowan AE, Winston CA, Davis MM, et al. Influenza vaccination status and influenza-related perspectives and practices among US physicians. Am J Infect Control 2006; 34:164-169.
61. Mallari J, Goad J, Wu J, et al. Knowledge, attitudes, and practices regarding influenza vaccination among health professional students. J Am Pharm Assoc 2007; 47:498-502.
62. Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007; 25:5283-5289.
63. Arenas-Garcia L, Garcia-Corpus ML, Martinez-Gurrion LA, et al. Acceptance of influenza vaccination by nursing personnel in Mexico. J Hosp Infect 2007; 66:381-383.
64. Maltezou HC, Maragos A, Katerelos P, et al. Influenza vaccination acceptance among health-care workers in Greece: a nationwide survey. Vaccine 2008; 26:1408-1410.
65. Maltezou HC, Maragos A, Raftopoulos V, et al. Strategies to increase influenza vaccine uptake among health-care workers in Greece. Scand J Infect Dis 2008; 40:266-268.
66. Sartor C, Tissot-Dupont H, Zandotti C, et al. Use of a mobile cart influenza program for vaccination of hospital employees. Infect Control Hosp Epidemiol 2004; 25:918-922.
67. McCullers JA, Speck KM, Williams BF, et al. Increased influenza vaccination of healthcare workers at a pediatric cancer hospital: results of a comprehensive influenza vaccination campaign. Infect Control Hosp Epidemiol 2006; 27:77-79.
68. Whitley RJ. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol 2007; 3:755-767.
69. Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006; 367:303-313.
70. Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first three years of their use. Antimicrob Agent Chemother 2006; 50:2395-2402.
71. European Influenza Surveillance Scheme. http://www.eiss.org/documents/ antiviral/EISS-VIRGIL-antiviral-resistance-H1N1-update-20-02-2008-14-36.pdf [Accessed 29 February 2008].
72. European Centre for Disease Prevention and Control. Emergence of seasonal influenza viruses type A/H1N1 with oseltamivir resistance in some European countries at the start of the 2007-2008 influenza season. Interim ECDC Risk Assessment (27th January 2008). http://ecdc.europa.eu/pdf/080127-os.pdf [Assessed 29 February 2008].
73. CDC. Infection and control guidance for the prevention and control of influenza in acute-care facilities (November 15, 2007). www.cdc.gov/flu/ professionals/infectioncontrol/healthcarefacilities.htm [Accessed 29 February 2008].
74. Bocchini JA Jr, Baltimore RS, Bernstein HH, et al. American Academy of Pediatrics Committee on Infectious Diseases. Infection prevention and control in pediatric ambulatory settings. Pediatrics 2007; 120: 650-665.
75. French Ministry of Health. Protocol for chemoprophylaxis of persons residing in closed communities at high-risk in case of an influenza epidemic, during the circulation of influenza virus (No 444; September 17, 2004). www.sante.gouv.fr/htm/dossiers/grippe-collectivite/protocole.htm [Accessed 29 February 2008].
76. Shijubo N, Yamada G, Takahashi M, et al. Experience with oseltamivir in the control of nursing home influenza A outbreak. Intern Med 2002; 41:366-370.
77. Chang YM, Li WC, Huang CT, et al. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. J Hosp Infect 2008; 68:83-87. Prophylaxis and treatment with oseltmivir successfully interrupted an influenza A outbreak in a long-term care facility.
78. Vu D, Peck AJ, Nichols WG, et al. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case control study. Clin Infect Dis 2007; 45:187-193. Oseltamivir was safe and effective in controlling an influenza outbreak among transplant recipients in a closed facility.
79. Bowles SK, Lee W, Simor AE, et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999-2000. J Am Geriatr Soc 2002; 50:608-616.
80. Lee C, Loeb M, Phillips A, et al. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol 2000; 21:700-704.
81. National Institute for Health and Patient Excellence (NHS), Flu prevention - amantadine and oseltamivir: guidance. http://www.nice.org.uk/ guidance/TA67 [Accessed 29 February 2008].